Divis Labs

Divi's Laboratories Q1 net jumps 63% to Rs 167 crore

Pharmaceuticals firm Divi's Laboratories reported 63.15 percent increase in standalone net profit for the quarter ended 30 June, 2012 at Rs 167.38 crore, driven by higher sales realisation.

Market action could shift to small and mid-caps now

Neither the Sensex nor the Nifty is showing any decisive directional trend. Interest in the stocks that comprise these indices is low. The action may shift to trading opportunities in small and mid-cap shares.